Evaluating Criticism Of The Fda Accelerated Approval Pathway - Ema Evaluation Of Drugs That Have Been Withdrawn Following Accelerated Approval By The Fda
May 1, 2014, 00:00
10.1016/j.jval.2014.03.086
https://www.valueinhealthjournal.com/article/S1098-3015(14)00137-5/fulltext
Title :
Evaluating Criticism Of The Fda Accelerated Approval Pathway - Ema Evaluation Of Drugs That Have Been Withdrawn Following Accelerated Approval By The Fda
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00137-5&doi=10.1016/j.jval.2014.03.086
First page :
A13
Section Title :
Health Care Use and Policy Studies
Open access? :
No
Section Order :
191